The Role of the Clinical Nurse Specialist From the Perspective of Parents of Children Born With Cleft Lip and/or Palate in the United Kingdom

被引:0
作者
Searle, Aidan [1 ]
Neville, Patricia [2 ]
Ryan, Sara [4 ]
Waylen, Andrea [3 ]
机构
[1] NIHR Biomed Res Ctr Nutr Theme, Educ & Res Ctr, Bristol, Avon, England
[2] Univ Bristol, Bristol Dent Sch, Social Sci, Bristol, Avon, England
[3] Univ Bristol, Fac Hlth Sci, Bristol Dent Sch, Social Sci, Bristol, Avon, England
[4] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
基金
美国国家卫生研究院;
关键词
centralization; cleft lip and/or palate; cleft treatment pathway; clinical nurse specialist; multidisciplinary team; qualitative; BACTERIAL RNA-POLYMERASE; NUCLEOSIDE-ANALOG;
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Purpose/Aim: This qualitative study explores parents' perspectives of the clinical nurse specialist (CNS) after diagnosis of cleft lip and/or palate and while preparing for/after lip or palate closure and other events on the cleft treatment pathway in the United Kingdom. Design: Parents with children on the "cleft treatment pathway'' were recruited from multiple regions across the United Kingdom. In-depth interviews were conducted with 24 parents of children born with cleft lip and/or palate. Methods: Thematic analysis identified 4 key themes: relationship with CNS, information provision, preoperative care and multidisciplinary team (MDT), and postoperative support. Results: Clinical nurse specialists are a highly valued point of contact and act as a trusted mediator between parents and other professionals in the MDT. Clinical nurse specialists are important gatekeepers in providing support and information and developing trust after diagnosis and birth and throughout the cleft treatment pathway. Conclusion: The present findings affirm the emotional, social, and informational support that the CNS can offer parents whose children are on a cleft treatment pathway. The CNS is a vital member of the cleft service MDT.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 10 条
  • [1] [Anonymous], 2017, CHEM ENG NEWS, V95, P1
  • [2] [Anonymous], 2019, ScienceDaily
  • [3] Centers for Disease Control and Prevention, 2013, Antibiotic Resistance Threats in the United States, 2013
  • [4] Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase
    Chellat, Mathieu F.
    Riedl, Rainer
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (43) : 13184 - 13186
  • [5] Ebright R, TRANSCRIPTION STRUCT
  • [6] Gallegos J., 2017, WASHINGTON POST
  • [7] Structures of RNA polymerase-antibiotic complexes
    Ho, Mary X.
    Hudson, Brian P.
    Das, Kalyan
    Arnold, Eddy
    Ebright, Richard H.
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2009, 19 (06) : 715 - 723
  • [8] Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase
    Maffioli, Sonia I.
    Zhang, Yu
    Degen, David
    Carzaniga, Thomas
    Del Gatto, Giancarlo
    Serina, Stefania
    Monciardini, Paolo
    Mazzetti, Carlo
    Guglierame, Paola
    Candiani, Gianpaolo
    Chiriac, Alina Iulia
    Facchetti, Giuseppe
    Kaltofen, Petra
    Sahl, Hans-Georg
    Deho, Gianni
    Donadio, Stefano
    Ebright, Richard H.
    [J]. CELL, 2017, 169 (07) : 1240 - +
  • [9] Roos R, 2017, CIDRAP NEWS 0615
  • [10] World Health Organization, ANT RES FACT SHEET